Component

Unidentified betanin oxidation products in the MPO/nitrite assay

Experimentally generated mixture with unresolved molecular structures; not an identified human metabolite.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Unidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay.

    Experimental context and source evidence
    dose
    Experimental betanin addition; concentration not specified in accessed abstract
    duration
    Oxidation time courses; duration not specified in accessed abstract
    evidence_access
    Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
    evidence_scope
    literature_reviewed; source-derived curation, not universally established human effects
    experimental_model
    Isolated human LDL and MPO/nitrite biochemical system
    limitations
    Oxidation products were not chemically identified; clinical LDL lowering was not tested.
    nutrient_topic
    Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
    organism
    Isolated human LDL and MPO/nitrite biochemical system
    plain_language
    Unidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay.
    primary_references
    Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
    route
    In vitro addition
    tissue
    LDL lipid compartment

    Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 197–205

    Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Isolated human LDL and MPO/nitrite biochemical system · source_derived_draft · unverified_draft

    ## betalains-oxidation-products Unidentified products generated by MPO/nitrite oxidation of betanin also inhibited LDL oxidation in the assay. Model/species: Isolated human LDL and MPO/nitrite biochemical system Tissue: LDL lipid compartment Exposure: Experimental betanin addition; concentration not specified in accessed abstract Route: In vitro addition Duration: Oxidation time courses; duration not specified in accessed abstract Limits: Oxidation products were not chemically identified; clinical LDL lowering was not tested. Primary reference: Betanin inhibits the myeloperoxidase/nitrite-induced oxidation of human low-density lipoproteins. (2007). https://pubmed.ncbi.nlm.nih.gov/17364963/ DOI: 10.1080/10715760601038783
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards